Literature DB >> 8643173

Mitral annular calcification in CAPD patients with a low degree of hyperparathyroidism. An analysis of other possible risk factors.

M J Fernandez-Reyes1, M Auxiliadora Bajo, P Robles, R Selgas, J Oliver, G Del Peso, G Garcia, C Jimenez, F Garcia-Gallego.   

Abstract

Chronic renal failure has been suggested as a risk factor for mitral annular calcification (MAC), a degenerative process of the mitral annulus. The objective of the present study was to define MAC risk factors at the start of dialysis and 'de-novo' appearance after medium- or long-term CAPD, in a non-selected population (135 patients) with a low degree of secondary hyperparathyroidism. Echocardiographic studies were performed at the beginning of CAPD and every 1-1.5 years thereafter. Diagnosis of MAC was established by M mode and 2-D study. Seventeen of 135 patients studied at the start of dialysis showed MAC. Patients who showed MAC were older and presented a higher mean systolic blood pressure. The other anthropometric/demographic parameters did not show statistically significant differences. MAC thickness: mean 6.21 +/- 3.65 mm (range 3-17.2 mm). The posterior annulus was universally affected and in four patients the anterior annulus was involved. Seventeen of 76 patients included in the follow-up study developed MAC. No significant differences for demography, except age, with MAC patients being older, were found. Mean time on CAPD until de-novo MAC diagnosis was 49.7 +/- 26.9 months. MAC thickness: mean 4.97 +/- 1.6 mm (range 3-8.42 mm). The posterior annulus was affected in all patients except for one and in four patients the anterior annulus was involved. The most remarkable echocardiographic feature is the almost constant association of MAC with left atrial dilatation (LAD). The last one does not seem a consequence of mitral insufficiency, or systolic dysfunction. Left ventricular hypertrophy was universally found, with no different intensities for patients with or without MAC. In conclusion, a high incidence of mitral annular calcification has been found in CAPD patients. Our data do not confirm the role of classical invoked risk factors. Blood CaP product under 75, a moderate to mild degree of hyperparathyroidism and/or hypertension with left ventricular hypertrophy do not seem to be isolated risk factors during the CAPD period. Length of time on CAPD, for unknown reasons, seems to favour the appearance of MAC. At starting dialysis, high systolic blood pressure and left ventricular hypertrophy seem to be related to MAC. Diabetes appears to represent an additional risk factor. Further research on mitral annular calcification pathogenesis and its consequences is urgently required.

Entities:  

Mesh:

Year:  1995        PMID: 8643173

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  Calcification of the small bowel in renal hyperparathyroidism.

Authors:  G J Morris-Stiff; D J Bowrey; V Balaji; W A Jurewicz
Journal:  J R Soc Med       Date:  1998-08       Impact factor: 5.344

2.  Myocardial calcinosis in chronic renal failure.

Authors:  Ashley E Kempf; Maryam Golshan Momeni; Farhood Saremi
Journal:  J Radiol Case Rep       Date:  2009-02-01

Review 3.  Cardiovascular disease as a late complication of end-stage renal disease in children.

Authors:  Jaap W Groothoff; Marc R Lilien; Nicole C A J van de Kar; Eric D Wolff; Jean Claude Davin
Journal:  Pediatr Nephrol       Date:  2004-11-10       Impact factor: 3.714

Review 4.  Physiopathological approach to infective endocarditis in chronic hemodialysis patients: left heart versus right heart involvement.

Authors:  Yassamine Bentata
Journal:  Ren Fail       Date:  2017-11       Impact factor: 2.606

5.  Healthcare use and costs before and after parathyroidectomy in patients on dialysis.

Authors:  Vasily Belozeroff; Kerry Cooper; Gregory Hess; Chun-Lan Chang
Journal:  BMC Health Serv Res       Date:  2013-07-02       Impact factor: 2.655

6.  Risk factors for heart valve calcification in chronic kidney disease.

Authors:  Shu Rong; Xin Qiu; Xiucai Jin; Minghua Shang; Yixin Huang; Zhihuan Tang; Weijie Yuan
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.